Australia's most trusted
source of pharma news
Thursday, 18 September 2025
Thursday, 18 September 2025
Subscribe
Login
News Headlines
News Headlines
News
Novartis keeps on shopping
Posted 18 September 2025 AM
Novartis is on a shopping spree. In its latest splurge, the Swiss giant has signed an agreement with US-based Monte Rosa Therapeutics to develop molecular glue degraders for immune-mediated diseases.
For US$120 million up front and a potential total of US$5.7 billion including milestone payments, options and royalties, Novartis gets an exclusive licence to an undisclosed discovery target, and options to license two programs from Monte Rosa’s growing preclinical immunology portfolio.
To see the whole article, please login
Posted 18 September 2025 AM
Novartis is on a shopping spree. In its latest splurge, the Swiss giant has signed an agreement with US-based Monte Rosa Therapeutics to develop molecular glue degraders for immune-mediated diseases.
For US$120 million up front and a potential total of US$5.7 billion including milestone payments, options and royalties, Novartis gets an exclusive licence to an undisclosed discovery target, and options to license two programs from Monte Rosa’s growing preclinical immunology portfolio.
To see the whole article, please login
Popular
Latest Jobs
Pharma in Focus Jobs
Marketing & Communications (2)
Sales & Customer Relations (25)
- GP Sales Representative - Pharmaceutical Sales (Brisbane Western Suburbs) - Brisbane
- GP Sales Representative (VIC) - VIC
- Key Account Manager - Melbourne
- Key Account Manager Haematology - Brisbane
- Key Account Manager - Haematology - Sydney
- Customer Service Representative - Belrose
- GP Sales Representative - Primary Care (NSW South Coast) - NSW South Coast
- GP Sales Representative – Primary Care (VIC Geelong) - VIC
- Hybrid Sales Representative - Pharmaceutical Sales (Albury NSW) - Albury NSW
- Hospital Sales Representative - Queensland
- Key Account Manager - Sydney
- Territory Manager - Perth
- Devices Territory Manager - Auckland
- Hybrid Medical Representative - Sydney
- GP Sales Representative - Sunshine Coast
- Customer Service Representative - Macquarie Park
- Key Account Manager - Melbourne
- Medical Representative - Perth
- Medical Representative - Melbourne
- Territory Manager - Perth
- Hospital Specialist Representative - Brisbane
- Territory Manager NSW/ACT - Sydney
- Territory Manager - Animal Health - Brisbane
- Business Development Manager - Sydney
- Customer Service Representative - Belrose
Clinical & Medical, R&D (12)
- Medical Science Liaison - Sydney
- Senior Clinical Research Scientist - Sydney
- Industrial Hygienist - Blacktown
- Hybrid Medical Representative - Sydney
- Clinical Trial Investigator - Victoria
- Medical Representative - Perth
- Medical Representative - Melbourne
- Warehouse & Medical Kit Coordinator - Brisbane
- Medical Administration - Chatswood
- Clinical Research Manager - Melbourne
- Clinical Trial Nurse Manager - Melbourne
- Medical Device Coordinator - Macquarie Park
Regulatory, Pharmacovigilance & QA (6)
- Quality Control Technician - Jacana
- Quality Manager - Ryde
- Head of Regulatory, Development & Commercialisation - Australia (Remote - Flexible)
- Senior Regulatory Affairs Associate - Melbourne
- Mulitple Roles: Regulatory Affairs Associate / Senior Associate - various
- Senior QA Associate - Broadmeadows
Devices (1)
Other (9)
- Customer Operations Specialist - 4am Start - Macquarie Park
- Associate Finance Director - Macquarie Park
- Senior Recruitment Consultant - Sydney
- Legal Counsel - Macquarie Park
- Customer Operations Specialist - 4am Start - Macquarie Park
- Senior Recruitment Consultant - Sydney
- Senior HR Business Partner - Victoria
- Loan Kit Technician - Melbourne
- EHS Compliance Support - Blacktown
MORE NEWS
Email this article to a friend
From:
Print this article
Copyright Notice
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.